SCHEMBL2807870

SCHEMBL2807870

CN(C)C=Nc1ccc(C2Cc3cnc(NCc4cccc(Cl)c4)nc3-c3ccccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.41
FGFR2 P21802 2/20 0.41
CSF1R P07333 1/20 0.38
FGFR3 P22607 1/20 0.38
DRD1 P21728 1/20 0.36
HTR2A P28223 1/20 0.36
ACHE P22303 1/20 0.35
BACE1 P56817 1/20 0.35
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
APP P05067 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807869 1.00 FGFR1 (0.41) FGFR1FGFR2CSF1RFGFR3DRD1
SCHEMBL14644885 1.00 FGFR1 (0.41) FGFR1FGFR2CSF1RFGFR3DRD1
SCHEMBL16360405 0.84 FGFR1 (0.41) FGFR1FGFR2CSF1RFGFR3FLT3
SCHEMBL2802907 0.84 FGFR1 (0.41) FGFR1FGFR2CSF1RFGFR3ACHE
SCHEMBL2489018 0.84 FGFR1 (0.41) FGFR1FGFR2CSF1RFGFR3ACHE
SCHEMBL2489019 0.84 FGFR1 (0.41) FGFR1FGFR2CSF1RFGFR3ACHE
SCHEMBL2513192 0.81 FGFR1 (0.40) FGFR1FGFR2FGFR3
SCHEMBL2513190 0.81 FGFR1 (0.40) FGFR1FGFR2FGFR3
SCHEMBL2803281 0.80 FGFR1 (0.54) FGFR1FGFR2CSF1RFGFR3ACHE
SCHEMBL2806030 0.77 FGFR1 (0.44) FGFR1FGFR2CSF1RFGFR3ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CSF1R 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.